首页> 外文期刊>Journal of cardiovascular translational research >Transplantation of Cardiac Mesenchymal Stem Cell-Derived Exosomes Promotes Repair in Ischemic Myocardium
【24h】

Transplantation of Cardiac Mesenchymal Stem Cell-Derived Exosomes Promotes Repair in Ischemic Myocardium

机译:心脏间充质干细胞的移植促进缺血心肌促进缺血性心肌

获取原文
获取原文并翻译 | 示例
           

摘要

Our previous study demonstrated the beneficial effects of exosomes secreted by cardiac mesenchymal stem cells (C-MSC-Exo) in protecting acute ischemic myocardium from reperfusion injury. Here, we investigated the effect of exosomes from C-MSC on angiogenesis in ischemic myocardium. We intramyocardially injected C-MSC-Exo or PBS into the infarct border zone after induction of acute mouse myocardial infarction (MI). We observed that hearts treated with C-MSC-Exo exhibit improved cardiac function compared to control hearts treated with PBS at one month after MI. Capillary density and Ki67-postive cells were significantly higher following treatment with C-MSC-Exo as compared with PBS. Moreover, C-MSC-Exo treatment increased cardiomyocyte proliferation in infarcted hearts. In conclusion, intramyocardial delivery of C-MSC-Exo after myocardial infarction enhances cardiac angiogenesis, promotes cardiomyocyte proliferation, and preserves heart function. C-MSC-Exo constitute a novel form of cell-free therapy for cardiac repair.
机译:我们以前的研究表明,心间充质干细胞(C-MSC-EXO)分泌的外来肌肉分泌的有益效果免受再灌注损伤的急性缺血性心肌。在这里,我们研究了外来肌瘤在缺血心肌中C-MSC的影响。在诱导急性小鼠心肌梗死(MI)后,我们在肌内注射C-MSC-EXO或PBS进入梗塞边界区。我们观察到用C-MSC-EXO治疗的心脏表现出改善的心功能,与MI后一个月用PBS治疗的心脏治疗。在与PBS相比,用C-MSC-EXO处理后,毛细密度和Ki67末期细胞显着提高。此外,C-MSC-EXO治疗增加了梗死的心脏心肌细胞增殖。总之,心肌梗死后C-MSC-EXO的肌动态递送增强心肌血管生成,促进心肌细胞增殖,并保持心脏功能。 C-MSC-EXO构成了一种用于心脏修复的无细胞疗法形式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号